Ibrolipim
Ibrolipim attenuates high glucose-induced endothelial dysfunction in cultured human umbilical vein endothelial cells via PI3K/Akt pathway.
Product Specifications
CAS Number
133208-93-2
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
451.25
Molecular Formula
Br1C19H20N2O4P1
Notes
Research use only, not for human use.
Receptor
Lipoprotein lipase (LPL)
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog